Skip to main content
Erschienen in: Urolithiasis 5/2004

01.10.2004 | Original Paper

Expression of transforming growth factor β in renal cell carcinoma and matched non-involved renal tissue

verfasst von: Dionisios Mitropoulos, Aspasia Kiroudi, Evangelia Christelli, Efraim Serafetinidis, Anastasios Zervas, Ioannis Anastasiou, Constantinos Dimopoulos

Erschienen in: Urolithiasis | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

TGFβ1 is one of several cytokines produced by proximal tubular and renal cancer cells. Previous studies have been mainly focused on determining plasma or serum TGFβ levels, its effect on RCC cultures, and the expression of TGFβ mRNA. Cancerous and autologous normal kidney samples were obtained from 24 patients treated by radical nephrectomy. TGFβ1 expression was determined using a semi quantitative Western blot analysis and immunohistochemistry. Blot densities and immunohistochemical expression intensities in normal and neoplastic tissue were compared, and subsequently correlated to tumor stage, histological type and nuclear grade. All tissue samples examined expressed TGFβ1; mean tumor to non-involved kidney spot density ratio correlated with advancing stage and higher nuclear grade. The overexpression of TGFβ1 in certain RCCs may partially explain their resistance to the growth suppression action of TGFβ. The correlation with tumor stage and grade indicates a possible role in the development of metastatic potential as well as in host’s immune response modulation.
Literatur
1.
Zurück zum Zitat Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R (1992) Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha. Cancer Res 52:3335PubMed Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R (1992) Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha. Cancer Res 52:3335PubMed
2.
Zurück zum Zitat Border W, Noble N (1995) Targeting TGFβ for treatment of diseases. Nat Med 1:1000PubMed Border W, Noble N (1995) Targeting TGFβ for treatment of diseases. Nat Med 1:1000PubMed
3.
Zurück zum Zitat Cardillo MR, Lazzereschi D, Galdini O, Di Silverio F, Colletta G (2001) Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma. Anal Quant Cytol Histol 23:109PubMed Cardillo MR, Lazzereschi D, Galdini O, Di Silverio F, Colletta G (2001) Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma. Anal Quant Cytol Histol 23:109PubMed
4.
Zurück zum Zitat Cerwenka A, Bevec D, Majdic O, Knapp W, Holter W (1994) TGF-beta 1 is a potent inducer of human effector T cells. J Immunol 153:4367PubMed Cerwenka A, Bevec D, Majdic O, Knapp W, Holter W (1994) TGF-beta 1 is a potent inducer of human effector T cells. J Immunol 153:4367PubMed
5.
Zurück zum Zitat Chang SG, Shin C, Rho SK, Kim DK, Kim JH (1998) Cytokine production in primary histoculture by human normal kidney, renal cell carcinoma and benign renal angiomyolipoma tissues. Anticancer Res 18:4195PubMed Chang SG, Shin C, Rho SK, Kim DK, Kim JH (1998) Cytokine production in primary histoculture by human normal kidney, renal cell carcinoma and benign renal angiomyolipoma tissues. Anticancer Res 18:4195PubMed
6.
Zurück zum Zitat Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Wiiliams RD, Bringman TS, Berger WH (1987) Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptors by human tumors. Cancer Res 47:707PubMed Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Wiiliams RD, Bringman TS, Berger WH (1987) Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptors by human tumors. Cancer Res 47:707PubMed
7.
Zurück zum Zitat Filmus J, Kerbel RS (1993) Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression. Curr Opin Oncol 5:123PubMed Filmus J, Kerbel RS (1993) Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression. Curr Opin Oncol 5:123PubMed
8.
Zurück zum Zitat Gomella LG, Sargent ER, Linehan WM, Kasid A (1989) Transforming growth factor-beta inhibits the growth of renal cell carcinoma in vitro. J Urol 141:1240 Gomella LG, Sargent ER, Linehan WM, Kasid A (1989) Transforming growth factor-beta inhibits the growth of renal cell carcinoma in vitro. J Urol 141:1240
9.
Zurück zum Zitat Gomella LG, Sargent ER, Wade TP, Anglard P, Linehan WM, Kasid A (1989) Expression of transforming growth factor α in normal human adult kidney and of transforming growth factors α and β1 in renal cell carcinoma. Cancer Res 49:6972PubMed Gomella LG, Sargent ER, Wade TP, Anglard P, Linehan WM, Kasid A (1989) Expression of transforming growth factor α in normal human adult kidney and of transforming growth factors α and β1 in renal cell carcinoma. Cancer Res 49:6972PubMed
10.
Zurück zum Zitat Hall S, Hsieh T-C, Ng C-Y, Mallouh C, Wu JM (1996) Control of renal carcinoma TC-1 growth, cyclin/kinase and nm23 expression by IFN-γ and TGF-β. Anticancer Res 16:1755PubMed Hall S, Hsieh T-C, Ng C-Y, Mallouh C, Wu JM (1996) Control of renal carcinoma TC-1 growth, cyclin/kinase and nm23 expression by IFN-γ and TGF-β. Anticancer Res 16:1755PubMed
11.
Zurück zum Zitat Hegele A, Vagra Z, Von Knobloch R, Heidenreich A, Kropf J, Hofmann R (2002) TGFβ1 in patients with renal cell carcinoma. Urol Res 30:126CrossRefPubMed Hegele A, Vagra Z, Von Knobloch R, Heidenreich A, Kropf J, Hofmann R (2002) TGFβ1 in patients with renal cell carcinoma. Urol Res 30:126CrossRefPubMed
12.
Zurück zum Zitat Herman ME, Katzenellenbogen BS (1994) Alterations in transforming growth factor α and β production and cell responsiveness during the progression of MCF-7 human breast cancer cells to eostrogen–autonomous growth. Cancer Res 54:5876 Herman ME, Katzenellenbogen BS (1994) Alterations in transforming growth factor α and β production and cell responsiveness during the progression of MCF-7 human breast cancer cells to eostrogen–autonomous growth. Cancer Res 54:5876
13.
Zurück zum Zitat Junker U, Knoefel B, Rebstock K, Steiner T, Wunderlich H, Junker K, Reinhold D (1996) Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. Cytokine 8:794CrossRefPubMed Junker U, Knoefel B, Rebstock K, Steiner T, Wunderlich H, Junker K, Reinhold D (1996) Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. Cytokine 8:794CrossRefPubMed
14.
Zurück zum Zitat Junker U, Haufe CC, Nuske K, Rebstock K, Steiner T, Wunderlich H, Junker K, Reinhold D (2000) Elevated plasma TGFbeta1 in renal diseases: cause or consequence ? Cytokine 12:1084CrossRefPubMed Junker U, Haufe CC, Nuske K, Rebstock K, Steiner T, Wunderlich H, Junker K, Reinhold D (2000) Elevated plasma TGFbeta1 in renal diseases: cause or consequence ? Cytokine 12:1084CrossRefPubMed
15.
Zurück zum Zitat Kerbel RS (1992) Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm. Am J Pathol 141:519PubMed Kerbel RS (1992) Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm. Am J Pathol 141:519PubMed
16.
Zurück zum Zitat Knoefel B, Nuske K, Steiner T, Junker K, Kosmehl H, Rebstock K, Reinhold D, Junker U (1997) Renal cell carcinomas produce IL-6, IL-10, IL-11 and TGF beta-1 in primary cultures and modulate T-lymphocyte blast formation. J Interferon Cytokine Res 17:95PubMed Knoefel B, Nuske K, Steiner T, Junker K, Kosmehl H, Rebstock K, Reinhold D, Junker U (1997) Renal cell carcinomas produce IL-6, IL-10, IL-11 and TGF beta-1 in primary cultures and modulate T-lymphocyte blast formation. J Interferon Cytokine Res 17:95PubMed
17.
Zurück zum Zitat Kundu SD, Kim IY, Zelner D, Janulis L, Goodwin S, Engel JD, Lee C (1998) Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal cell carcinoma cell line, Renca. J Urol 160:1883 Kundu SD, Kim IY, Zelner D, Janulis L, Goodwin S, Engel JD, Lee C (1998) Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal cell carcinoma cell line, Renca. J Urol 160:1883
18.
Zurück zum Zitat Laemli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680PubMed Laemli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680PubMed
19.
Zurück zum Zitat Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics 1999. CA Cancer J Clin 49:8PubMed Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics 1999. CA Cancer J Clin 49:8PubMed
20.
Zurück zum Zitat Lyons RM, Moses HL (1990) Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 187:467PubMed Lyons RM, Moses HL (1990) Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 187:467PubMed
21.
Zurück zum Zitat Maniatis T, Fritch EF and Sambrook KJ (1982) Detection and Analysis of proteins expressed from cloned genes. In: Maniatis T, Fritch EF, Sambrook KJ (eds) Molecular cloning: a laboratory manual. Cold Spring Harbor, New York, p 18.47 Maniatis T, Fritch EF and Sambrook KJ (1982) Detection and Analysis of proteins expressed from cloned genes. In: Maniatis T, Fritch EF, Sambrook KJ (eds) Molecular cloning: a laboratory manual. Cold Spring Harbor, New York, p 18.47
22.
Zurück zum Zitat Maniatis T, Fritsch EF, Sambrook KJ (1982) Detection and analysis of proteins expressed from cloned genes. In: Maniatis T, Fritch EF, Sambrook KJ (eds) Molecular cloning: a laboratory manual. Cold Spring Harbor, New York, p 18.60 Maniatis T, Fritsch EF, Sambrook KJ (1982) Detection and analysis of proteins expressed from cloned genes. In: Maniatis T, Fritch EF, Sambrook KJ (eds) Molecular cloning: a laboratory manual. Cold Spring Harbor, New York, p 18.60
23.
Zurück zum Zitat Markowitz SD, Roberts AB (1996) Tumor suppressor activity of the TGFβ pathway in human cancers. Cytokine Growth Factor Rev 7:93CrossRefPubMed Markowitz SD, Roberts AB (1996) Tumor suppressor activity of the TGFβ pathway in human cancers. Cytokine Growth Factor Rev 7:93CrossRefPubMed
24.
Zurück zum Zitat Massague J (1990) The transforming growth factor β family. Annu Rev Cell Biol 6:597PubMed Massague J (1990) The transforming growth factor β family. Annu Rev Cell Biol 6:597PubMed
25.
Zurück zum Zitat Michel K, Tso CL, Mulders P, Kernion JD, Beldegrun A (1997) Expression of TGFβ1 in renal cell carcinoma (RCC); putative role of TGFβ as tumor infiltrating lymphocyte (TIL) suppressor. J Urol 157 [Suppl]:376 Michel K, Tso CL, Mulders P, Kernion JD, Beldegrun A (1997) Expression of TGFβ1 in renal cell carcinoma (RCC); putative role of TGFβ as tumor infiltrating lymphocyte (TIL) suppressor. J Urol 157 [Suppl]:376
26.
Zurück zum Zitat Miyazono K, Ichijo H and Heldin CH (1993) Transforming growth factor β: Latent forms, binding proteins and receptors. Growth Factors 8:11PubMed Miyazono K, Ichijo H and Heldin CH (1993) Transforming growth factor β: Latent forms, binding proteins and receptors. Growth Factors 8:11PubMed
27.
Zurück zum Zitat Mulder KM, Ramey MR, Hoosen NM, Levine AE, Hinshaw XH, Brattain DE, Brattain MG (1988) Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line. Cancer Res 48:7120PubMed Mulder KM, Ramey MR, Hoosen NM, Levine AE, Hinshaw XH, Brattain DE, Brattain MG (1988) Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line. Cancer Res 48:7120PubMed
28.
Zurück zum Zitat Olive C, Cheung C, Nicol D, Falk MC (1998) Expression of cytokine mRNA transcripts in renal cell carcinoma. Immunol Cell Biol 76:357CrossRefPubMed Olive C, Cheung C, Nicol D, Falk MC (1998) Expression of cytokine mRNA transcripts in renal cell carcinoma. Immunol Cell Biol 76:357CrossRefPubMed
29.
Zurück zum Zitat Phillips AO, Steadman R, Topley N, Williams JD (1995) Elevated D-glucose concentrations modulate TGF-beta1 synthesis by human cultured renal proximal tubular cells .The permissive role of platelet-derived growth factor. Am J Pathol 147:362PubMed Phillips AO, Steadman R, Topley N, Williams JD (1995) Elevated D-glucose concentrations modulate TGF-beta1 synthesis by human cultured renal proximal tubular cells .The permissive role of platelet-derived growth factor. Am J Pathol 147:362PubMed
30.
Zurück zum Zitat Polyak K (1996) Negative regulation of cell growth by TGF beta. Biochim Biophys Acta 1242:185CrossRefPubMed Polyak K (1996) Negative regulation of cell growth by TGF beta. Biochim Biophys Acta 1242:185CrossRefPubMed
31.
Zurück zum Zitat Ramp U, Jaquet K, Reinecke P, Nitsch T, Gabbert HE, Gerharz CD (1997) Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma. Lab Invest 76:739PubMed Ramp U, Jaquet K, Reinecke P, Nitsch T, Gabbert HE, Gerharz CD (1997) Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma. Lab Invest 76:739PubMed
32.
Zurück zum Zitat Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche WS, Wakefield LA, Heine UI, Liotta LA, Falanga V, Kehl JH, Fauci AS (1986) Transforming growth factor β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 83:4167PubMed Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche WS, Wakefield LA, Heine UI, Liotta LA, Falanga V, Kehl JH, Fauci AS (1986) Transforming growth factor β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 83:4167PubMed
33.
Zurück zum Zitat Sankar S, Mahooti–Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA (1996) Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 97:1436PubMed Sankar S, Mahooti–Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA (1996) Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 97:1436PubMed
34.
Zurück zum Zitat Sene AP, Hunt L, McMahon RF, Carroll RN (1992) Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br J Urol 70:125PubMed Sene AP, Hunt L, McMahon RF, Carroll RN (1992) Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br J Urol 70:125PubMed
35.
Zurück zum Zitat Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Gocke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76PubMed Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Gocke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76PubMed
36.
Zurück zum Zitat Storkel S, Eble J, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K (1997) Classification of renal cell carcinoma: Workgroup No1, Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:987CrossRefPubMed Storkel S, Eble J, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K (1997) Classification of renal cell carcinoma: Workgroup No1, Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:987CrossRefPubMed
37.
Zurück zum Zitat Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350PubMed Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350PubMed
38.
Zurück zum Zitat Van Brussel JP, Mickisch GH (1999) Prognostic factors in renal cell and bladder cancer. BJU Int 83:902CrossRefPubMed Van Brussel JP, Mickisch GH (1999) Prognostic factors in renal cell and bladder cancer. BJU Int 83:902CrossRefPubMed
39.
Zurück zum Zitat Wechsel HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E (1999) Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res 19:1537PubMed Wechsel HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E (1999) Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res 19:1537PubMed
40.
Zurück zum Zitat Wunderlich H, Steiner T, Junker U, Knoefel B, Schlichter A, Schubert J (1996) Serum transforming growth factor β1 in patients with renal cell carcinoma. J Urol 157:1602 Wunderlich H, Steiner T, Junker U, Knoefel B, Schlichter A, Schubert J (1996) Serum transforming growth factor β1 in patients with renal cell carcinoma. J Urol 157:1602
41.
Zurück zum Zitat Wunderlich H, Steiner T, Kosmehl H, Junker U, Reinhold D, Reichelt O, Zermann DH, Schubert J (1998) Increased transforming growth factor beta 1 plasma level in patients with renal cell carcinoma: a tumor-specific marker? Urol Int 60:205CrossRefPubMed Wunderlich H, Steiner T, Kosmehl H, Junker U, Reinhold D, Reichelt O, Zermann DH, Schubert J (1998) Increased transforming growth factor beta 1 plasma level in patients with renal cell carcinoma: a tumor-specific marker? Urol Int 60:205CrossRefPubMed
Metadaten
Titel
Expression of transforming growth factor β in renal cell carcinoma and matched non-involved renal tissue
verfasst von
Dionisios Mitropoulos
Aspasia Kiroudi
Evangelia Christelli
Efraim Serafetinidis
Anastasios Zervas
Ioannis Anastasiou
Constantinos Dimopoulos
Publikationsdatum
01.10.2004
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 5/2004
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-003-0360-z

Weitere Artikel der Ausgabe 5/2004

Urolithiasis 5/2004 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.